加载中
NASDAQHealthcareMedical - Devices
最新数据
US$2.48
−US$0.115 · -4.43%
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
常规交易时段
US$2.48
−US$0.115 · -4.43%
盘中时间采用ET。市场数据可能有所延迟。
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
日内区间
当前US$2.48
52周区间
当前US$2.48
盘中时间采用ET。市场数据可能有所延迟。
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
日内区间
当前US$2.48
52周区间
当前US$2.48
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1892.5万 USD | 487.87万 USD | 4.04万 USD | — | 36.51万 USD |
| 销货成本 | 1034.1万 USD | 223.88万 USD | 13.5万 USD | — | 26.06万 USD |
| 毛利 | 858.4万 USD | 263.98万 USD | −9.46万 USD | — | 10.46万 USD |
| 研究与开发 | 393.6万 USD | 326.73万 USD | 148.56万 USD | — | 216.27万 USD |
| 销售、一般及管理费用 | 908.5万 USD | 1154.95万 USD | 342.77万 USD | 427.91万 USD | 498.57万 USD |
| 营业费用 | 1302.1万 USD | 1481.69万 USD | 491.33万 USD | 427.91万 USD | 714.84万 USD |
| 利息收入 | — | — | 152.69万 USD | 163.04万 USD | — |
| 利息支出 | 263.9万 USD | 449.78万 USD | 54.48万 USD | 2.31万 USD | 19.3万 USD |
| 折旧和摊销 | 13.1万 USD | 23.1万 USD | 48.07万 USD | — | 95.07万 USD |
| 营业利润 | −443.7万 USD | −1217.7万 USD | −500.8万 USD | −427.91万 USD | −704.38万 USD |
| 净利润 | −2108.3万 USD | −898.49万 USD | −609.9万 USD | −277.43万 USD | −541.51万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
